Latest news
Loading news…
Addition Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. South San Francisco, California, United States 11-50 employees For Profit
Addition Therapeutics develops RNA-only therapeutics using PRINT technology for genetic medicine.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
3
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 18
Company Info
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 11
- HQ
- South San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.2
- Trend (30d)
- -0.4
- Trend (90d)
- -1
- Last leadership hire
- Dec 17, 2025
Key People at Addition Therapeutics
Chief Scientific Officer
CEO
Founder
3
professional contacts at Addition Therapeutics
Contact execs at Addition Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Addition Therapeutics
Loading news…
FAQs about Addition Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.